The 20 Best ALK-Positive Non-Small Cell Lung Cancer Doctors Near Me in Somerset, PA
Find the Top ALK-Positive Non-Small Cell Lung Cancer Experts and Specialists
MediFind found 6 doctor with experience in ALK-Positive Non-Small Cell Lung Cancer near Somerset, PA. Of these, 5 are Experienced and 1 are Distinguished.
UPMC Thoracic Surgery
Neil A. Christie, MD, is an assistant professor of surgery in the Department of Cardiothoracic Surgery and director of LIFE Bronchoscopy and Early Lung Cancer Detection Program. He specializes in select areas of thoracic surgery including minimally invasive thoracic surgery, antireflux surgery, fluorescent bronchoscopy, and thoracic stereotactic radiosurgery.Dr. Christie is board-certified in thoracic surgery. He received an undergraduate degree from Queen's University, Kingston, Ontario. He then completed a medical degree at the University of Toronto. Dr. Christie completed a residency in cardiothoracic surgery at the Cleveland Clinic, Cleveland, Ohio, and a fellowship in minimally invasive thoracic surgery at the University of Pittsburgh School of Medicine.Dr. Christie is a member of the Canadian Medical Association, American College of Surgeons, American Medical Association, and the Society of American Gastrointestinal Endoscopic Surgeons.Learn more about Dr. Christie's research interests. Dr. Christie is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, Endoscopy, and Thymectomy.
UPMC Hillman Cancer Center At UPMC Somerset
Aiman Daghestani, MD, specializes in medical oncology and is certified by the American Board of Internal Medicine. He is affiliated with UPMC Somerset and UPMC Altoona. He completed his medical degree at Aleppo University School of Medicine, residencies at MedStar Franklin Square Medical Center and Mercy Hospital and Medical Center, and fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Daghestani is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Paget Disease of the Breast, Muscle Invasive Bladder Cancer, Urothelial Cancer, and Familial Pancreatic Cancer.
Center For Community Hospitalist Medicine
Olutunde Odeyemi, MD, specializes in hospital medicine and is board-certified in internal medicine by the American Board of Internal Medicine. He practices at Center for Community Hospitalist Medicine. Dr. Odeyemi completed his medical education at College of Medical Sciences and residency at Jersey City Medical Center. Dr. Odeyemi is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Liver Failure, Gallbladder Disease, Endoscopy, and Ureteroscopy.
UPMC HCC Somerset UPMC Somerset
Imran Idrees is an Oncologist in Somerset, Pennsylvania. Dr. Idrees is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Thrombocytopenia, Myelodysplastic Syndrome (MDS), Hemangioma Thrombocytopenia Syndrome, and Carcinoid Syndrome.
UPMC Hillman Cancer Center At UPMC Somerset
Katlyn Hostetler is a Physician Assistant in Somerset, Pennsylvania. Ms. Hostetler is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Conemaugh Meyersdale Outpatient Center-Family Health Care Rhc
Ashley Berkley is a primary care provider, practicing in Family Medicine in Meyersdale, Pennsylvania. Dr. Berkley has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Maturity Onset Diabetes of the Young.
Last Updated: 04/28/2026


